Clinical Trial Update: Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 study of tiragolumab plus atezolizumab in non-squamous non-small cell lung cancer with untreated brain metastases has been terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Liza Villaruz, MD | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-01-22